UBS AM’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
124,153
+17,264
+16% +$148K ﹤0.01% 2338
2025
Q4
$1.11M Sell
106,889
-3,877
-4% -$40.7K ﹤0.01% 2108
2025
Q3
$980K Sell
110,766
-78,954
-42% -$563K ﹤0.01% 2018
2025
Q2
$1.09M Buy
189,720
+37,588
+25% +$230K ﹤0.01% 2368
2025
Q1
$1M Buy
152,132
+20,414
+15% +$159K ﹤0.01% 2304
2024
Q4
$1.15M Buy
131,718
+9,050
+7% +$130K ﹤0.01% 2305
2024
Q3
$2.4M Sell
122,668
-2,436
-2% -$49.4K ﹤0.01% 1950
2024
Q2
$2.58M Buy
125,104
+38,438
+44% +$790K ﹤0.01% 1859
2024
Q1
$1.85M Buy
86,666
+4,810
+6% +$93.5K ﹤0.01% 1720
2023
Q4
$1.18M Hold
81,856
﹤0.01% 1943
2023
Q3
$747K Buy
81,856
+41,887
+105% +$425K ﹤0.01% 2122
2023
Q2
$489K Hold
39,969
﹤0.01% 2334
2023
Q1
$489K Sell
39,969
-5,950
-13% -$74.2K ﹤0.01% 2334
2022
Q4
$570K Hold
45,919
﹤0.01% 2127
2022
Q3
$627K Sell
45,919
-294,543
-87% -$4.54M ﹤0.01% 2239
2022
Q2
$6.24M Sell
340,462
-10,069
-3% -$145K ﹤0.01% 1135
2022
Q1
$5.64M Sell
350,531
-21,219
-6% -$306K ﹤0.01% 1304
2021
Q4
$5.2M Sell
371,750
-11,385
-3% -$184K ﹤0.01% 1398
2021
Q3
$7.18M Sell
383,135
-9,528
-2% -$180K ﹤0.01% 1221
2021
Q2
$8.19M Buy
392,663
+92,687
+31% +$2.3M ﹤0.01% 1188
2021
Q1
$8.48M Buy
299,976
+40,660
+16% +$1.29M ﹤0.01% 1134
2020
Q4
$8.47M Buy
259,316
+220,616
+570% +$7.75M ﹤0.01% 1114
2020
Q3
$1.19M Buy
38,700
+460
+1% +$10.2K ﹤0.01% 1771
2020
Q2
$623K Buy
38,240
+22,724
+146% +$328K ﹤0.01% 2027
2020
Q1
$154K Sell
15,516
-8,277
-35% -$94.7K ﹤0.01% 2347
2019
Q4
$327K Buy
23,793
+121
+0.5% +$1.79K ﹤0.01% 2350
2019
Q3
$359K Buy
+23,672
New +$421K ﹤0.01% 2399

Other funds holding KURA